1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Summary of characteristics of 6 patients who underwent stenting of vertebral artery−PICA
Patient No. Age (yr)/Sex Presentation Diagnosis Treatment Stent (mm) Imaging/Clinical F/U (mo) GOS
1^a 58/F Coexisting PICA aneurysm Stent coil Enterprise 4.5 × 22 11/24 5
2 49/M SAH Vertebral artery dissection Vertebral artery occlusion with stenting Enterprise 4.5 × 37 12/23 5
3 50/M Headache Vertebral artery dissection Vertebral artery occlusion with stenting Enterprise 4.5 × 22 6/6 5
4 55/M Dizziness Vertebral artery−PICA stenosis Stent Enterprise 4.5 × 28 6/6 5
5 49/M SAH PICA aneurysm Stent coil Solitaire 4 × 15 6/6 5
6^a 68/F Coexisting PICA aneurysm Stent coil Enterprise 4.5 × 22 1/3 5

Note:—F/U indicates Follow-up; GOS, Glasgow Outcome Score.


↵a In patient 2, “coexisting” means that there is another asymptomatic lesion.